Lantheus Holdings, Inc. (LNTH) stock
LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3010% above fair value
$101.59+0.34 (+0.34%)
Close on Nov 13, 2026Market cap $6.63BP/E 25.1Yield –
Lantheus total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Lantheus's total debt was $571.74M at Sep 30, 2026. For fiscal 2025 it was $569.42M, up 0.6% from the year before. Over ten years it grew 4.9% a year on average. The highest annual figure on record is $569.42M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $569.42M | +0.6% |
| FY2024 | Dec 31, 2024 | $566.25M | +0.7% |
| FY2023 | Dec 31, 2023 | $562.49M | +0.8% |
| FY2022 | Dec 31, 2022 | $558.07M | +219.3% |
| FY2021 | Dec 31, 2021 | $174.76M | -20.0% |
| FY2020 | Dec 31, 2020 | $218.40M | +12.5% |
| FY2019 | Dec 31, 2019 | $194.07M | -27.2% |
| FY2018 | Dec 31, 2018 | $266.46M | -0.6% |
| FY2017 | Dec 31, 2017 | $268.14M | -3.6% |
| FY2016 | Dec 31, 2016 | $278.11M | -21.3% |
| FY2015 | Dec 31, 2015 | $353.51M | -10.0% |
| FY2014 | Dec 31, 2014 | $392.86M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $571.74M | +0.5% |
| Q2 FY2026 | Jun 30, 2026 | $571.05M | +0.6% |
| Q1 FY2026 | Mar 31, 2026 | $570.41M | +0.6% |
| Q4 FY2025 | Dec 31, 2025 | $569.42M | +0.6% |
| Q3 FY2025 | Sep 30, 2025 | $568.81M | +0.6% |
| Q2 FY2025 | Jun 30, 2025 | $567.64M | +0.6% |
| Q1 FY2025 | Mar 31, 2025 | $566.85M | +0.6% |
| Q4 FY2024 | Dec 31, 2024 | $566.25M | +0.7% |
| Q3 FY2024 | Sep 30, 2024 | $565.33M | +0.7% |
| Q2 FY2024 | Jun 30, 2024 | $564.06M | +0.8% |
| Q1 FY2024 | Mar 31, 2024 | $563.20M | +0.8% |
| Q4 FY2023 | Dec 31, 2023 | $562.49M | +0.8% |
| Q3 FY2023 | Sep 30, 2023 | $561.28M | +235.2% |
| Q2 FY2023 | Jun 30, 2023 | $559.62M | +229.7% |
| Q1 FY2023 | Mar 31, 2023 | $558.96M | +224.5% |
| Q4 FY2022 | Dec 31, 2022 | $558.07M | +219.3% |
| Q3 FY2022 | Sep 30, 2022 | $167.43M | -5.5% |
| Q2 FY2022 | Jun 30, 2022 | $169.73M | -5.5% |
| Q1 FY2022 | Mar 31, 2022 | $172.25M | -5.2% |
| Q4 FY2021 | Dec 31, 2021 | $174.76M | -20.0% |
| Q3 FY2021 | Sep 30, 2021 | $177.10M | -20.5% |
| Q2 FY2021 | Jun 30, 2021 | $179.62M | -20.9% |
| Q1 FY2021 | Mar 31, 2021 | $181.73M | -5.2% |
| Q4 FY2020 | Dec 31, 2020 | $218.40M | +12.5% |
| Q3 FY2020 | Sep 30, 2020 | $222.81M | +13.4% |
| Q2 FY2020 | Jun 30, 2020 | $227.15M | +14.2% |
| Q1 FY2020 | Mar 31, 2020 | $191.63M | -28.0% |
| Q4 FY2019 | Dec 31, 2019 | $194.07M | -27.2% |
| Q3 FY2019 | Sep 30, 2019 | $196.54M | -26.4% |
| Q2 FY2019 | Jun 30, 2019 | $198.84M | -25.6% |
| Q1 FY2019 | Mar 31, 2019 | $266.15M | -0.6% |
| Q4 FY2018 | Dec 31, 2018 | $266.46M | -0.6% |
| Q3 FY2018 | Sep 30, 2018 | $266.88M | -0.5% |
| Q2 FY2018 | Jun 30, 2018 | $267.30M | -0.5% |
| Q1 FY2018 | Mar 31, 2018 | $267.72M | -0.5% |
| Q4 FY2017 | Dec 31, 2017 | $268.14M | -3.6% |
| Q3 FY2017 | Sep 30, 2017 | $268.27M | – |
| Q2 FY2017 | Jun 30, 2017 | $268.68M | – |
| Q1 FY2017 | Mar 31, 2017 | $269.09M | – |
| Q4 FY2016 | Dec 31, 2016 | $278.11M | – |
See a number that looks wrong?